Table 1.
Demographics and outcomes (n = 103 subjects)
| Median age (range) y.o. | 35 (1–75) |
|---|---|
| Male: female | 69: 34 |
| Distribution of cases in age groupa, N(%) | |
| 1 - ≤5 years | 2/153 (1.3%) |
| 6 - ≤18 years | 19/190 (10%) |
| 19 - ≤45 years | 53/378 (14%) |
| > 45 years | 29/254 (11.4%) |
| Day of onset (median, range), days | 5 (1–12) |
| Length of stay (median, range), days | 6 (1–36) |
| Antibiotics use from 90 subjects with documented history, N (%) | 76 (84%) |
| Ceftriaxone | 17 (22.4%) |
| Ciprofloxacin | 9 (11.8%) |
| Levofloxacin | 9 (11.8%) |
| Cefixime | 2 (2.6%) |
| Cefotaxime, Amoxicillin, Ampicillin, Cefadroxil, Meropenem, Chloramphenicol, Cefoperazone, Sulbactam, Cotrimoxazole | 1 (1.3%), each |
| Combination 2–3 antibiotics | 30 (39.5%) |
| Outcomes, N (%) | |
| Recovered | 72 (69.9%) |
| Recovered with sequelaeb | 24 (23.3%) |
| Died | 7 (6.8%) |
| By sitesa, N (%) | |
| Bandung | 22/189 (11.6%) |
| Denpasar | 16/101 (15.8%) |
| Jakarta | 7/87 (8%) |
| Makassar | 5/131 (3.8%) |
| Semarang | 21/191 (10.9%) |
| Surabaya | 26/156 (16.7%) |
| Yogyakarta | 6/120 (5%) |
afrom 975 subjects tested for Rickettsia typhi
bLethargy, arthralgia, anorexia, headache, dizziness, cough